Focus, Focus, Focus – How Quick Can You Focus?
High throughput demands fast diagnostic turnaround. To properly provide a diagnosis of a stained sputum slide requires a microscopist approximately 7-10 minutes for each Auramine slide and 10-15...
View ArticleIntelligent Laboratory Workflow System
In the previous blogs our focus has been concentrated on the slide reading and evaluation processes of TBDx™. While these processes are fundamental to the technology, there are other technical modules...
View ArticleTBDx and Its Fit in the World of TB Diagnostics
A View from 35,000 Feet TBDx™ revolutionizes the 105-year old TB sputum microscopy diagnostic process. It creates an innovative diagnostic paradigm that augments the almost symbiotic relationship...
View ArticleInternational Presentation Concludes a Combined TBDx and Molecular TB...
On April 9, 2012 we posted a blog entitled Combining TBDx with Other Detection Technologies. The blog illustrated how TBDx™ could be used, in a layered diagnostic protocol, to identify the most highly...
View ArticleWhy Does It Take So Long To Introduce “Disruptive” Medical Technology
Whether the technology is routine or disruptive it can be received with considerable skepticism, especially if it results in a substantial shift to an existing paradigm. It is the nature of the...
View ArticleTBDx – What Does It All Mean?
In this series of blog posts we have introduced you to TBDx™ and how the journey to automatically detect TB bacilli in stained sputum slides using a digital camera, slide loader, microscope, and...
View ArticleTBDx “Proof of Concept” Evaluation Is Published In PLoS One
The initial evaluation of TBDx TM, “Proof-of-Concept” Evaluation of an Automated Sputum Smear Microscopy System for Tuberculosis Diagnosis, undertaken by The Aurum Institute, was published in the...
View ArticleTesting TBDx Algorithmic Precision Using Artificial Sputum ‘Panel Slides’
In a previous blog we disclosed the results of a 181 case study, with sensitivity and specificity performance measured using culture as the ‘gold standard’. Further, those results were presented by...
View ArticleTom Ramsay Awarded 2013 Alumnus of Notable Achievement
Tom Ramsay (VP of Research) has been selected from hundreds of thousands of candidates to receive the University of Minnesota’s 2013 Alumnus of Notable Achievement. The College of Liberal Arts has...
View ArticleTBDx Computer Vision Technology Excels In Johns Hopkins Slide Challenge
The TB Clinical Diagnostic Research Consortium (CDRC), an organization funded by the National Institute for Allergy and Infectious Diseases of the National Institutes of Health and managed by Johns...
View ArticleOpportunity Awaits TBDx in South Africa
The team leaves Wednesday for Johannesburg, South Africa for an important evaluation of our TBDx technology that has been in the planning stages for the past several months. The evaluation will take...
View ArticleGovernment of Nigeria to Clinically Evaluate TBDx™ in June
Tuberculosis is a major public health problem in Nigeria, and the country is 4th among the 22 countries with the highest TB burden worldwide. The World Health Organization estimates incident and...
View Article… AND ANOTHER OFFICIAL APPROVAL … TBDx™ to be Evaluated in Uganda as...
The Internal Review Board for the Joint Clinical Research Centre (JCRC) in Kampala, Uganda recently approved a protocol to study and evaluate TBDx™ and the use of automated sputum microscopy as part of...
View ArticleTBDx™ Evaluation in South Africa Well-Planned and Executed
In its most thorough external evaluation yet, TBDx™ was the beneficiary of a highly skilled and professional staff from the National Institute for Communicable Diseases (NICD) in Johannesburg, who...
View ArticleTBDx South African Evaluation Update
It has been approximately one month since the Company completed its processing requirements under the TBDx™ South African Evaluation Protocol. As mentioned in previous blogs, our processing of 1,249...
View ArticleEncouraging Results Continue to Emerge from TBDx™ Evaluation
One very important hallmark, in any technology evaluation, is the ability to consistently produce similar results across multiple independent tests. Can the performance of TBDx™ in external laboratory...
View ArticleSmear Microscopy – Can it Remain Relevant in an Expanding Molecular...
This is the first post in a three-part blog series on smear microscopy – it’s continuing role in TB diagnostics, how it can be improved, and how it can be combined with GeneXpert and other molecular...
View ArticleThis Month TBDx™ Introduces Unique Advantages to TB Diagnostics
At the end of this month we will be departing for Paris to participate in the 44th Union World Conference on Lung Health. From October 29th to November 3rd, the company will showcase TBDx™, its...
View ArticleAPVS and FIND Collaboration Targets Automated TB Detection in Developing...
March 19, 2014 APVS and FIND Collaboration Targets Automated TB Detection in Developing Countries Collaboration to evaluate TBDx™ computer-vision software platform Leesburg, VA (19 March 2014) – APVS...
View ArticleApplied Visual Sciences Grieves the Passing of Michael Trudnak, Chairman &...
The Board of Directors of Applied Visual Sciences today reports, with deep sadness, the passing of Michael W. Trudnak, age 61, the company’s co-founder, Chairman and Chief Executive Officer. Mr....
View Article
More Pages to Explore .....